The RPAS/Drone and Advanced Air Mobility (AAM) industries are growing rapidly, making this an exciting opportunity to work on the leading edge of emerging aviation and help shape the future of the ...
The biotechnology firm Replimune approaches a critical juncture. On April 10, 2026, the U.S. Food and Drug Administration ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results